Jevantique Lo Interactions
There are 459 drugs known to interact with Jevantique Lo (ethinyl estradiol/norethindrone), along with 24 disease interactions, and 8 alcohol/food interactions. Of the total drug interactions, 52 are major, 360 are moderate, and 47 are minor.
- View all 459 medications that may interact with Jevantique Lo
- View Jevantique Lo alcohol/food interactions (8)
- View Jevantique Lo disease interactions (24)
Most frequently checked interactions
View interaction reports for Jevantique Lo (ethinyl estradiol / norethindrone) and the medicines listed below.
- Adderall (amphetamine / dextroamphetamine)
- Atarax (hydroxyzine)
- baclofen
- clobetasol topical
- Cymbalta (duloxetine)
- hydrochlorothiazide
- ketamine
- Klonopin (clonazepam)
- levothyroxine
- mupirocin topical
- Myrbetriq (mirabegron)
- Norflex (orphenadrine)
- Plaquenil (hydroxychloroquine)
- Synthroid (levothyroxine)
- Topamax (topiramate)
- topiramate
- trazodone
- triamcinolone topical
- Xolair (omalizumab)
- Zanaflex (tizanidine)
Jevantique Lo alcohol/food interactions
There are 8 alcohol/food interactions with Jevantique Lo (ethinyl estradiol / norethindrone).
Jevantique Lo disease interactions
There are 24 disease interactions with Jevantique Lo (ethinyl estradiol / norethindrone) which include:
- smoking
- abnormal genital bleeding
- abnormal vaginal bleeding
- carcinomas (estrogenic)
- hypercalcemia in breast cancer
- hypertension
- thromboembolism/cardiovascular
- hepatic neoplasms
- breast malignancy
- liver disease
- thromboembolism
- angioedema
- gallbladder disease
- hypercalcemia
- hyperlipidemia
- liver disease
- melasma
- depression
- fluid retention
- glucose intolerance
- retinal thrombosis
- thyroid function tests
- hyperlipidemia
- weight gain
More about Jevantique Lo (ethinyl estradiol / norethindrone)
- Jevantique Lo consumer information
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: contraceptives
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.